Where is Kisqali (ribociclib) approved as an adjuvant treatment for early breast cancer (and how to get it if it's not yet in your country)?

How to get the new vitiligo ointment from a trusted supplier in India?

Odronextamab may not have gotten FDA approval, but it's on its way to getting the EMA's green light. Here's what that means for you as a US patient.

Why was Blenrep pulled off the market, is it still available, and will it get approval again?

When will non-US patients have access to Enhertu as a tumor-agnostic treatment.

How is the new vigabatrin oral solution different from other treatments for infantile spasms? And can it be a Sabril alternative?

When will the newest treatment for extensive-stage small cell lung cancer be available to patients in Europe (and worldwide)?

Can lurbinectedin be used to treat Ewing sarcoma and neuroendocrine tumors? The latest data and likely approval timelines.

Relyvrio is being pulled off the market. What does it mean for you and your treatment?

Who qualifies for treatment with lecanemab? And how non-US patients can get the medicine if their doctor prescribes it.

Fruquintinib clinical trials in gastric cancer are showing promising results. Will the medicine be approved for this indication soon?

Will Zepzelca be available to European and UK patients soon? Here's what we know, and your options if you can't wait.

Can givinostat be used to treat polycythemia vera? Here's what clinical trial data show.

When will the new nonsteroidal treatment for Duchenne be available in the EU and the UK?

Could Tivdak treat more than cervical cancer? Here's the latest overview of trials focusing on ovarian, head and neck cancers, and more.

When will European patients have access to the newest FDA-approved neuroblastoma treatment?

Iptacopan will soon be approved in Europe, but when will it be available to patients?

Zynyz(retifanlimab) may have a larger role to play in cancer treatment. Find out the latest research in renal cell carcinoma and more.

When will Wainua be available to patients in Europe and the UK? The latest news and all your options in the meantime.

Toripalimab is being studied as a treatment of NSCLC, oesophageal cancer, melanoma, and more. What does research tell us, and what does it mean for you?

Can Balversa be used to treat breast cancer? What we know from research, and what it means for you.

Toripalimab may get its EMA and MHRA approvals soon, but when will it be available to patients? All you need to know.

When will Tivdak be available to patients in Europe and the UK? All you need to know, and all your options to get the treatment quicker.

Zynyz is close to EMA approval, but it won't be immediately available everywhere in Europe. Here's how to get the treatment at your own timeline.

Erdafitinib may get its EMA approval in 2024, but when will it be available on the market?

Can tazemetostat treat bladder cancer, prostate cancer, and more? Here's the latest research.

Tazverik seems a long way from EMA approval. If you can't wait, here are all your options to safely get the treatment.

Get the latest updates on Tofersen's EMA approval timeline and discover alternative ways to access the medicine in the meantime.